Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Regulus Therapeutics PE Ratio 2011-2019 | RGLS

Current and historical p/e ratio for Regulus Therapeutics (RGLS) from 2011 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Regulus Therapeutics PE ratio as of December 13, 2019 is 0.00.
  
Regulus Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-13 0.74 0.00
2019-09-30 0.72 $-1.85 0.00
2019-06-30 1.25 $-2.77 0.00
2019-03-31 1.02 $-4.03 0.00
2018-12-31 0.93 $-5.52 0.00
2018-09-30 2.37 $-6.22 0.00
2018-06-30 7.91 $-7.20 0.00
2018-03-31 8.61 $-10.56 0.00
2017-12-31 12.48 $-13.33 0.00
2017-09-30 15.00 $-16.21 0.00
2017-06-30 11.83 $-18.49 0.00
2017-03-31 19.80 $-18.37 0.00
2016-12-31 27.00 $-18.61 0.00
2016-09-30 39.60 $-15.73 0.00
2016-06-30 34.68 $-14.29 0.00
2016-03-31 83.16 $-14.41 0.00
2015-12-31 104.64 $-13.09 0.00
2015-09-30 78.54 $-17.05 0.00
2015-06-30 131.52 $-17.17 0.00
2015-03-31 203.28 $-15.73 0.00
2014-12-31 192.48 $-15.85 0.00
2014-09-30 81.96 $-11.52 0.00
2014-06-30 96.48 $-9.24 0.00
2014-03-31 108.24 $-8.16 0.00
2013-12-31 88.68 $-6.96 0.00
2013-09-30 113.16 $-8.28 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.000B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.340B 10.01
Zoetis (ZTS) United States $59.218B 35.42
Astellas Pharma (ALPMY) Japan $32.299B 16.13
Eisai (ESALY) Japan $21.220B 40.92
Grifols, S.A (GRFS) Spain $15.628B 20.48
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.262B 484.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.752B 17.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.480B 10.83
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $7.643B 31.09
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.443B 97.57
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.026B 18.07
FibroGen (FGEN) United States $4.157B 122.15
United Therapeutics (UTHR) United States $4.114B 0.00
Nektar Therapeutics (NKTR) United States $3.833B 0.00
Sage Therapeutics (SAGE) United States $3.761B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.591B 13.13
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.941B 0.00
ArQule (ARQL) United States $2.413B 0.00
Heron Therapeutics (HRTX) United States $2.302B 0.00
Zogenix (ZGNX) United States $2.136B 0.00
Xencor (XNCR) United States $2.127B 64.65
Portola Pharmaceuticals (PTLA) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.979B 63.10
ChemoCentryx (CCXI) United States $1.932B 0.00
Tilray (TLRY) Canada $1.903B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.899B 56.19
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.721B 0.00
USANA Health Sciences (USNA) United States $1.654B 17.64
Corcept Therapeutics (CORT) United States $1.527B 18.56
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.507B 10.29
Enanta Pharmaceuticals (ENTA) United States $1.295B 29.58
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.196B 0.00
Karyopharm Therapeutics (KPTI) United States $1.068B 0.00
Endo (ENDP) Ireland $1.066B 1.96
Radius Health (RDUS) United States $1.034B 0.00
Aerie Pharmaceuticals (AERI) United States $1.024B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.983B 0.00
Flexion Therapeutics (FLXN) United States $0.795B 0.00
Akebia Therapeutics (AKBA) United States $0.755B 0.00
Dermira (DERM) United States $0.702B 0.00
Collegium Pharmaceutical (COLL) United States $0.694B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
ImmunoGen (IMGN) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.535B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Organogenesis Holdings (ORGO) United States $0.445B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.445B 54.00
BioSpecifics Technologies Corp (BSTC) United States $0.440B 18.98
BioCryst Pharmaceuticals (BCRX) United States $0.439B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.436B 0.00
Harpoon Therapeutics (HARP) United States $0.435B 0.00
Molecular Templates (MTEM) United States $0.413B 0.00
Indivior (INVVY) United States $0.412B 1.49
OptiNose (OPTN) United States $0.393B 0.00
Recro Pharma (REPH) United States $0.381B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.375B 0.00
DURECT (DRRX) United States $0.371B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.30
Siga Technologies (SIGA) United States $0.369B 8.43
Corbus Pharmaceuticals Holdings (CRBP) United States $0.329B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.301B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.272B 0.00
GlycoMimetics (GLYC) United States $0.267B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.257B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Concordia (CXRXF) Canada $0.215B 0.00
Concert Pharmaceuticals (CNCE) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 32.00
AcelRx Pharmaceuticals (ACRX) United States $0.184B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Aquestive Therapeutics (AQST) United States $0.168B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.145B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.129B 0.00
CV Sciences (CVSI) United States $0.129B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.099B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.089B 0.00
Capnia (SLNO) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 23.91
Oasmia Pharmaceutical AB (OASMY) Sweden $0.079B 0.00
Champions Oncology (CSBR) United States $0.078B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Natural Alternatives (NAII) United States $0.058B 14.55
Genocea Biosciences (GNCA) United States $0.058B 0.00
Novan (NOVN) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Mast Therapeutics (SVRA) United States $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
IsoRay (ISR) United States $0.044B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Shineco (TYHT) China $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00